G

Guardian Pharmacy Services Inc
NYSE:GRDN

Watchlist Manager
Guardian Pharmacy Services Inc
NYSE:GRDN
Watchlist
Price: 30.64 USD 0.66% Market Closed
Market Cap: 1.9B USD
Section:
 

Relative Value

The Relative Value of one GRDN stock under the Base Case scenario is 23.4 USD. Compared to the current market price of 30.64 USD, Guardian Pharmacy Services Inc is Overvalued by 24%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRDN Relative Value
Base Case
23.4 USD
Overvaluation 24%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
5
vs Industry
50
Median 3Y
1.2
Median 5Y
1.2
Industry
2
Forward
1.3
More Details
48.2
P/E
P/E
Price to Earnings
48.2
vs History
0
vs Industry
Median 3Y
-12.9
Median 5Y
-12.9
Industry
18.2
Forward
44.6
More Details
22
P/OCF
P/OCF
Price to OCF
22
vs History
35
vs Industry
10
Median 3Y
20.8
Median 5Y
20.8
Industry
11.3
More Details
105.8
P/FCFE
P/FCFE
Price to FCFE
105.8
vs History
35
vs Industry
12
Median 3Y
96.8
Median 5Y
96.8
Industry
14.2
More Details
10.6
P/B
P/B
Price to Book Value
10.6
vs History
5
vs Industry
7
Median 3Y
9
Median 5Y
9
Industry
1.7
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
5
vs Industry
52
Median 3Y
1.2
Median 5Y
1.2
Industry
3.2
Forward
1.3
More Details
6.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.9
vs History
5
vs Industry
35
Median 3Y
5.9
Median 5Y
5.9
Industry
6.9
More Details
23.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.7
vs History
0
vs Industry
Median 3Y
-29.2
Median 5Y
-29.2
Industry
11.1
Forward
17.8
More Details
32.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.4
vs History
0
vs Industry
Median 3Y
-20
Median 5Y
-20
Industry
13.4
Forward
26.6
More Details
21.6
EV/OCF
EV/OCF
Enterprise Value to OCF
21.6
vs History
41
vs Industry
11
Median 3Y
20.6
Median 5Y
20.6
Industry
11.5
More Details
27.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.9
vs History
47
vs Industry
7
Median 3Y
28.4
Median 5Y
28.4
Industry
12.5
More Details
8.2
EV/IC
EV/IC
Enterprise Value to IC
8.2
vs History
0
vs Industry
13
Median 3Y
6.1
Median 5Y
6.1
Industry
1.7
More Details

Multiples Across Competitors

GRDN Competitors Multiples
Guardian Pharmacy Services Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Guardian Pharmacy Services Inc
NYSE:GRDN
1.9B USD 1.4 48.2 23.7 32.4
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
186.2B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
86.5B Zac 0 0 0 0
CH
Galderma Group AG
SIX:GALD
38.5B CHF 0 0 0 0
US
Coupang Inc
F:788
35.6B EUR 1.2 107.2 28.6 47.1
US
Reddit Inc
NYSE:RDDT
42.4B USD 22.3 121.5 144.1 152.8
US
Symbotic Inc
NASDAQ:SYM
37.2B USD 16.6 -2 197.8 -1 094.4 -496.4
US
CoreWeave Inc
NASDAQ:CRWV
34B USD 0 0 0 0
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
479.7T IDR 40.2 -111.1 2 405.9 2 405.9
P/S Multiple
Revenue Growth P/S to Growth
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average P/S: 72.2
1.4
10%
0.1
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
11%
N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
17%
N/A
US
Coupang Inc
F:788
1.2
16%
0.1
US
R
Reddit Inc
NYSE:RDDT
22.3
44%
0.5
US
Symbotic Inc
NASDAQ:SYM
16.6
22%
0.8
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
40.2
N/A N/A
P/E Multiple
Earnings Growth PEG
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average P/E: 1 074.4
48.2
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
49%
N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
85%
N/A
US
Coupang Inc
F:788
107.2
121%
0.9
US
R
Reddit Inc
NYSE:RDDT
121.5
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 197.8 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
Negative Multiple: -111.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average EV/EBITDA: 1 203.9
23.7
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
Coupang Inc
F:788
28.6
57%
0.5
US
R
Reddit Inc
NYSE:RDDT
144.1
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 094.4 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 405.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
G
Guardian Pharmacy Services Inc
NYSE:GRDN
Average EV/EBIT: 1 235.1
32.4
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
93%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-1%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
Coupang Inc
F:788
47.1
78%
0.6
US
R
Reddit Inc
NYSE:RDDT
152.8
N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -496.4 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 405.9
N/A N/A

See Also

Summary
GRDN intrinsic value, competitors valuation, and company profile.
DCF Valuation
GRDN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GRDN stock valuation using valuation multiples.
Wall Street Estimates
GRDN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GRDN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.